Publications & Papers

Preterm Birth: can we do better?

October 2016 – Published in the peer-reviewed journal, Proceedings in Obstetrics and Gynecology, the authors present a clinical treatment protocol for testing women early in pregnancy with a validated biomarker test for preterm birth risk, and administering recommended interventions based on a woman’s individual risk. The paper, Preterm Birth: can we do better? discusses:

Read More ›

Development and validation of a spontaneous preterm delivery predictor in asymptomatic women

May 2016 – This study, published as an Editor’s Choice article in the May issue of American Journal of Obstetrics & Gynecology, concluded that a serum-based molecular predictor (the PreTRM test) predicts an asymptomatic pregnant woman’s individual risk of spontaneous preterm delivery. This information, early in her pregnancy, may provide clinical utility in identifying women at increased risk at an early stage of pregnancy and allowing for clinical intervention that may help prolong gestational age and improve neonatal outcome.

Read More ›

Immunoassay Performance of a Preterm Birth Classifier

March 2016 – Sera Prognostics, Inc. presented data demonstrating correlation between ELISA and MRM-MS at the Society of Reproductive Investigation 2016 Annual Meeting. The results of the data demonstrated a two protein ELISA platform that is highly correlative with LC-MRM-MS results and generates sPTB risk scores with excellent classification performance.

Read More ›

July 14, 2021 - Sera today announced the pricing of its initial public offering of 4,687,500 shares of its common stock at a price to the public of $16.00 per share.

May 19, 2021-The PreTRM® Test Is Designed to Build a Foundation for Healthy Communities One Baby at a Time

Scroll to Top